Clinical Trial Update: Bioequivalence of a Single Subcutaneous Dose of Epoetin Beta in Healthy Japanese and Caucasian Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study assessing a single subcutaneous dose of epoetin beta in healthy Japanese and Caucasian male subjects to compare pharmacokinetics ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: InCROM Europe Clinical Research | Conditions: Chronic Kidney Failure, Anaemia | Phase 1 | Status: COMPLETED